Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Lowe Clayton said appetite suppression may also reduce consumption of foods that contain high amounts of water, including fruits and vegetables
Clinical Effectiveness: SURMOUNT-1 Trial (Tirzepatide 15 mg): Duration: 72 weeks Participants: 2,539 adults with obesity Average Weight Loss: 22.5% of body weight 10 mg Dose: 21.4% weight loss 5 mg Dose: 15.0% weight loss Placebo: 2.4% weight loss 5% Weight Loss: 96% of participants 10% Weight Loss: 89% of participants 15% Weight Loss: 78% of participants 20% Weight Loss: 63% of participants This is the best weight loss result ever achieved with medication in clinical trials
The GLP-1RAs group had a lower rate of adverse CVEs, including new-onset heart failure (HR 0.88
L-cell sensitivity to nutrients improves
FDA Labeling: Currently, the FDA label states that it is unknown if Tirzepatide passes into human milk
US$ 20.13
US$ 22.07
US$ 27.49
US$ 23.96
US$ 27.55
US$ 27.67
US$ 22.15
US$ 21.71
